Core Laboratories (CLB) Stock Price, News & Analysis

Company Overview

Core Laboratories N.V. (NYSE: CLB) is a global provider of reservoir description and production enhancement services for the oil and natural gas industry. The company helps exploration and production companies evaluate subsurface formations, characterize reservoirs and improve the recovery of hydrocarbons from existing fields.

Core Laboratories’ reservoir description activities include laboratory analysis of rock and fluid samples, core analysis, special core analysis, fluid and pressure-volume-temperature studies, geochemical services and related geological and petrophysical evaluations. These services support decisions involving reservoir modeling, field development, completion design and enhanced oil recovery.

Through its production enhancement business, the company provides services and technologies used to improve well completions and production performance. Its offerings include well and completion diagnostics, stimulation-related services, production optimization and technologies designed to address challenges in mature and unconventional reservoirs.

Founded in 1936, Core Laboratories serves customers in major oil- and gas-producing regions around the world through an international network of laboratories, service facilities and technical personnel. Its customers include national oil companies, independent exploration and production companies and integrated energy producers.

Key Stats

• Today's Range: $10.84 to $11.25
• 50-Day Range: $9.87 to $12.67
• 52-Week Range: $9.79 to $20.36
• Volume: 632,775 shs
• Average Volume: 576,150 shs
• Market Capitalization: $503.30 million
• P/E Ratio: 19.59
• Dividend Yield: 0.36%
• Price Target: $21.00
• Consensus Rating: Moderate Buy

Core Laboratories Stock Analysis - MarketRank™

Core Laboratories scored higher than 95% of companies evaluated by MarketBeat, and ranked 19th out of 252 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Core Laboratories has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.

Upside Potential

Core Laboratories has a consensus price target of $21.00, representing about 93.0% upside from its current price of $10.88.

Amount of Analyst Coverage

Core Laboratories has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 41.07%

Earnings Growth

Earnings for Core Laboratories are expected to grow by 41.07% in the coming year, from $0.56 to $0.79 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Core Laboratories is 19.41, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.04.

Price to Earnings Ratio vs. Sector

The P/E ratio of Core Laboratories is 19.41, which means that it is trading at a less expensive P/E ratio than the Energy sector average P/E ratio of about 20.85.

Price to Earnings Growth Ratio

Core Laboratories has a PEG Ratio of 2.24. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Core Laboratories has a P/B Ratio of 1.86. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.04% of the float of Core Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Core Laboratories has a short interest ratio ("days to cover") of 9.59.

Change versus previous month

Short interest in Core Laboratories has recently decreased by 3.76%, indicating that investor sentiment is improving.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Core Laboratories has a dividend yield of 0.36%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Core Laboratories does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Core Laboratories is 7.14%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 5.06% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.19

News Sentiment

Core Laboratories has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Energy companies.

News Coverage This Week

MarketBeat has tracked 14 news articles for Core Laboratories this week, compared to 2 articles on an average week.

Search Interest

2 people have searched for CLB on MarketBeat in the last 30 days.

MarketBeat Follows

Only 1 people have added Core Laboratories to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 3.6 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $53,900.00 in company stock, which represents 0.0108% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Core Laboratories insiders have bought more of their company's stock than they have sold. Specifically, they have bought $53,900.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

1.26% of the stock of Core Laboratories is held by insiders.

Percentage Held by Institutions

97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/29/2026
• Record date for 8/31 Dividend: 8/10/2026
• Ex-Dividend for 8/31 Dividend: 8/10/2026
• Dividend Payable: 8/31/2026
• Today: 9/21/2026
• Next Earnings (Estimated): 10/28/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Energy
• Industry: Energy Equipment & Services
• Sub-Industry: Oil & Gas Equipment & Services
• Current Symbol: NYSE:CLB
• CIK: 1958086
• Web: www.corelab.com
• Phone: (713) 328-2673
• Fax: N/A
• Employees: 3,300
• Year Founded: 1936

Price Target and Rating

• Average Price Target for Core Laboratories: $21.00
• High Price Target: $21.00
• Low Price Target: $21.00
• Potential Upside/Downside: +91.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.56
• Trailing P/E Ratio: 19.59
• Forward P/E Ratio: 19.59
• P/E Growth: 2.24
• Net Income: $29.67 million
• Net Margins: 5.10%
• Pretax Margin: 7.09%
• Return on Equity: 10.03%
• Return on Assets: 4.71%

Debt

• Debt-to-Equity Ratio: 0.41
• Current Ratio: 2.12
• Quick Ratio: 1.55

Sales & Book Value

• Annual Sales: $526.52 million
• Price / Sales: 0.96
• Cash Flow: $1.04 per share
• Price / Cash Flow: 10.53
• Book Value: $5.85 per share
• Price / Book: 1.88

Miscellaneous

• Outstanding Shares: 45,880,000
• Free Float: 45,307,000
• Market Cap: $503.30 million
• Optionable: Optionable
• Beta: 1.08